Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Radiation after surgery may keep adrenal cancer at bay

NCT ID NCT07141147

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 37 times

Summary

This study looks at whether giving radiation therapy after surgery can help prevent high-risk adrenocortical carcinoma from coming back. 58 patients who had their tumor removed will be randomly assigned to either receive radiation or just be watched. The main goal is to see if radiation improves the chance of staying cancer-free for three years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510060, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Radiation therapy (volumetric modulated arc therapy)

What this could lead to

If it works, this could show that adding radiotherapy after surgery helps prevent cancer from coming back in patients with high-risk adrenocortical carcinoma.

What could go wrong

This is a small early-stage trial with only 58 people, so results may not apply to everyone. Radiotherapy can cause side effects like damage to nearby organs.

Conditions

The condition(s) this trial relates to.

adrenal carcinoma adrenal cortex carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.